Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 136 clinical trials
featured
Reference Population Interval Evaluation with the Access Natriuretic Peptide Assay(S) – Subject Enrollment and Specimen Collection

We are seeking participants of ALL ages 21+, for a clinical research study to collect blood specimens and clinical data from individuals that DO NOT have heart failure. The specimens will be used at a later time for specific protocols to test normal ranges.

  • 131 views
  • 14 Jan, 2021
  • 2 locations
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

: HFPEF patients in the Swedish Heart Failure Registry (2550 patients) and HFPEF patients in US (650 patients). HFPEF defined as symptoms/signs of HF, elevated NTproBNP (B-type Natriuretic Peptide; N

natriuretic peptide
n-terminal pro-bnp
b-type natriuretic peptide
nt-probnp
atrial fibrillation
  • 46 views
  • 02 Jul, 2021
  • 148 locations
BNP Testing in Patients With SOB on Presentation to ED

A trial to examine whether a new heart failure blood test can improve the outcome of patients presenting to the Emergency Department with shortness of breath. We hypothesise that a BNP test performed in real-time in patients presenting to the Emergency Department with shortness of breath will help identify additional …

dyspnea
  • 43 views
  • 07 Nov, 2020
  • 1 location
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides Angiotensin and Neprilysin

The study measure multiple neurohormones in patients with heart failure being treated with Sacubitril/Valsartan in increasing doses over an 8 week period.

sacubitril/valsartan
chronic heart failure
ejection fraction
angiotensin
  • 5 views
  • 23 Jan, 2021
  • 1 location
ARNI in Asymptomatic Patients With Elevated Natriuretic Peptide and Elevated Left Atrial Volume Index eLEvation

diabetes or other risk factors for developing heart failure (elevated levels of natriuretic peptide and elevated left atrial volume index). Patients will be randomized to receive LCZ696 or valsartan (and

hypertension
natriuretic peptide
valsartan
sacubitril
diabetes
  • 0 views
  • 08 Nov, 2020
  • 1 location
A Study to Assess the Safety Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction

to evaluate the effect of IONIS-AGT-LRx weekly SC injection on plasma AGT concentration and N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) levels at each scheduled visit in chronic

  • 0 views
  • 30 Jul, 2021
  • 11 locations
Embryo Developmental Potential in a Novel 2-step IVM System

before IVM was initiated. This has been investigated and established using a meiotic blocker C-type Natriuretic peptide (CNP). The CNP peptide is present in high concentrations in the growing

  • 0 views
  • 27 Jan, 2021
  • 1 location
Acute Heart Failure - COngestion Discharge Evaluation

decongestion at the end of hospitalisation for AHF assessed by a standardised clinical score, a natriuretic peptide dosage or by cardiac and pulmonary ultrasound . Adapting treatment according to lung

pulmonary congestion
congestion
natriuretic peptide
  • 0 views
  • 29 Jan, 2021
  • 1 location
Right Ventricular Apical Versus True Mid-septal Pacing

concentration of N-terminal pro brain natriuretic peptide (NT-proBNP) from baseline to 6 months, 1 year and three years. Secondary end-points are changes in echo-parameters of LV synchrony. Discussion

  • 0 views
  • 22 Jun, 2021
  • 1 location
Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide

To compare the effects of 40 mg once-daily Torsemide ER to 40 mg twice daily Furosemide on 24-hour sodium excretion.

  • 5 views
  • 23 Jan, 2021
  • 1 location